AAAAAA
Results:
1-15
|
Results: 15
Authors:
Spina, E
Avenoso, A
Facciola, G
Salemi, M
Scordo, MG
Ancione, M
Madia, AG
Perucca, E
Citation: E. Spina et al., Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia, PSYCHOPHAR, 153(2), 2001, pp. 238-243
Authors:
Scordo, MG
Aklillu, E
Yasar, U
Dahl, ML
Spina, E
Ingelman-Sundberg, M
Citation: Mg. Scordo et al., Genetic polymorphism of cytochrome P4502C9 in a Caucasian and a black African population, BR J CL PH, 52(4), 2001, pp. 447-450
Authors:
Spina, E
Scordo, MG
Avenoso, A
Perucca, E
Citation: E. Spina et al., Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity, J CL PSYCH, 21(1), 2001, pp. 108-109
Authors:
Carlsson, B
Olsson, G
Reis, M
Walinder, J
Nordin, C
Lundmark, J
Scordo, MG
Dahl, ML
Bengtsson, F
Ahlner, J
Citation: B. Carlsson et al., Enantioselective analysis of citalopram and metabolites in adolescents, THER DRUG M, 23(6), 2001, pp. 658-664
Authors:
Spina, E
Avenoso, A
Scordo, MG
Ancione, M
Madia, A
Levita, A
Citation: E. Spina et al., No effect of reboxetine on plasma concentrations of clozapine, risperidone, and their active metabolites, THER DRUG M, 23(6), 2001, pp. 675-678
Authors:
Spina, E
Avenoso, A
Facciola, G
Scordo, MG
Ancione, M
Madia, A
Citation: E. Spina et al., Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine, THER DRUG M, 23(3), 2001, pp. 223-227
Authors:
Yasui-Furukori, N
Hidestrand, M
Spina, E
Facciola, G
Scordo, MG
Tybring, G
Citation: N. Yasui-furukori et al., Different enantioselective 9-hydroxylation of risperidone by the two humanCYP2D6 and CYP3A4 enzymes, DRUG META D, 29(10), 2001, pp. 1263-1268
Authors:
Brandolese, R
Scordo, MG
Spina, E
Gusella, M
Padrini, R
Citation: R. Brandolese et al., Severe phenytoin intoxication in a subject homozygous for CYP2C93, CLIN PHARM, 70(4), 2001, pp. 391-394
Authors:
Spina, E
Avenoso, A
Facciola, G
Scordo, MG
Ancione, M
Madia, AG
Ventimiglia, A
Perucca, E
Citation: E. Spina et al., Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics, PSYCHOPHAR, 148(1), 2000, pp. 83-89
Authors:
Spina, E
Avenoso, A
Salemi, M
Facciola, G
Scordo, MG
Ancione, M
Madia, A
Citation: E. Spina et al., Plasma concentrations of clozapine and its major metabolites during combined treatment with paroxetine or sertraline, PHARMACOPS, 33(6), 2000, pp. 213-217
Authors:
Spina, E
Avenoso, A
Facciola, G
Salemi, M
Scordo, MG
Giacobello, T
Madia, AG
Perucca, E
Citation: E. Spina et al., Plasma concentrations of risperidone and 9-hydroxyrisperidone: Effect of comedication with carbamazepine or valproate, THER DRUG M, 22(4), 2000, pp. 481-485
Authors:
Scordo, MG
Spina, E
Romeo, P
Dahl, ML
Bertilsson, L
Johansson, I
Sjoqvist, F
Citation: Mg. Scordo et al., CYP2D6 genotype and antipsychotic-induced extrapyramidal side effects in schizophrenic patients, EUR J CL PH, 56(9-10), 2000, pp. 679-683
Authors:
Scordo, MG
Spina, E
Facciola, G
Avenoso, A
Johansson, I
Dahl, ML
Citation: Mg. Scordo et al., Cytochrome P450 2D6 genotype and steady state plasma levels of risperidoneand 9-hydroxyrisperidone, PSYCHOPHAR, 147(3), 1999, pp. 300-305
Authors:
Avenoso, A
Facciola, G
Scordo, MG
Spina, E
Citation: A. Avenoso et al., No effect of the new antidepressant reboxetine on CYP2D6 activity in healthy volunteers, THER DRUG M, 21(5), 1999, pp. 577-579
Authors:
Facciola, G
Avenoso, A
Scordo, MG
Madia, AG
Ventimiglia, A
Perucca, E
Spina, E
Citation: G. Facciola et al., Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders, THER DRUG M, 21(3), 1999, pp. 341-345
Risultati:
1-15
|